Protocol of Diuretics Use in Congestive Therapy in Heart Failure (ProDUCT-HF)
Evaluation of an Optimization Protocol for Diuretics in the Decompensation of Chronic Heart Failure: Randomized Trial in Clusters With Sequential Permutation
Sponsor: CH Annecy Genevois
Listed as NCT03892148, this PHASE4 trial focuses on Acute Heart Failure and Chronic Heart Failure and remains completed. Sponsored by CH Annecy Genevois, it has been updated 9 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed
-
Sep 2024 — Feb 2026 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
May 2021 — May 2023 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
May 2019 — May 2020 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CH Annecy Genevois
- CH Issoire
- CH Moulins-Yzeure
- CH Puy en Velay
- CH Riom
- Hospices Civils de Lyon
- Hôpital de la Croix-Rousse
- Infirmerie Protestante de Lyon
- University Hospital, Clermont-Ferrand
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .